Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Index Level signals can help align your purchase or sale timing with market momentum, giving you a clearer framework for decisions and risk control.
25,526 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Investors are rotating into advertising agency stocks as digital channels drive measurable results. The top picks com...
Nvidia posted a record quarter with new revenue highs and strong guidance, signaling a shift to compute-driven growth...
Markets are betting that rates will edge lower this year, nudging investors toward income-focused and rate-sensitive ...
Ulta Beauty shares have tumbled in the wake of earnings, but analysts see a potential entry point. The ulta beauty pr...
Meta Platforms faced a $119 billion market-cap drop as regulators threaten stricter data, privacy and ad rules. Analy...
Analysts warn that Iran could use control of key internet cables as a new economic lever, risking a wave of volatilit...
A new $6,000 senior tax deduction comes with an income-based phase-out that can trim or erase relief for those who wo...
A rare Super El Niño could intensify Asia's energy crunch, threatening households and factories already squeezed by h...
A volatile oil backdrop in mid-2026 is creating a rare entry point for Exxon Mobil. With disciplined costs and robust...
Two Maverick Capital co-CIOs warn of an air pocket between AI infrastructure and productivity, signaling a market tur...
Two iconic brands face different paths to recovery. This deep-dive weighs Nike 12-Year and Lululemon 8-Year dynamics,...